Advertisement
Home Authors Posts by Keightley Amen

Keightley Amen

Keightley Amen
16 POSTS 0 COMMENTS

Frailty Markers Affect Outcomes Among Patients Receiving CAR T-Cell Therapy

“Hospital at Home” Program Is Safe and Useful in Hematologic Malignancies

New Efficacy and Safety Data on BTK Degrader BGB-16673

Second-Generation CAR T-Cell Therapy Effective in Relapsed/Refractory MCL

APP-Led Program Lessens Time to Diagnosis and Access to Care

Graded Mobility Better at Predicting VTE

Study Sets Threshold for Cost-Effective Iron-Deficiency Screening

Assessing Approvals and Costs of Classical Hematology Drugs

Digital Platform Has Early Success in Managing Rare Blood Disorder

Study: Obinutuzumab Safe and Effective in Relapsed or Refractory Follicular Lymphoma

12Page 1 of 2
Advertisement
© Copyright 2021 AMCP | 675 North Washington Street, Suite 220, Alexandria, VA 22314 | 703-684-2600 · Privacy Policy · meetings@amcp.org